Anúncio

pigmented lesion of oral cavity Assadawy.pptx

lecturer in oral implantology em Azhar University
1 de Apr de 2023
Anúncio

Mais conteúdo relacionado

Último(20)

Anúncio

pigmented lesion of oral cavity Assadawy.pptx

  1. pigmented Lesions of the Oral Mucosa Mohamed Ismail Assadawy Lecturer of Oral medicine , Periodontology ,Oral diagnosis and Oral radiology
  2. Oral pigmentation Pigmentation is defined as the process of deposition of pigments in tissues. Various diseases can lead to varied colorations in the mucosa. Pigmented lesions of oral cavity are due to the oral mucosa and perioral tissues can assume a variety of discolorations, including brown, blue, gray, and black oral pigmentation ranging from a focal macule to broad, diffuse tumefactions. the specific hue, duration, location, number, distribution,size, and shape of the pigmented lesion may also be of diagnostic importance
  3. Etiology increase of melanin production Increased number of melanocytes (melanocytosis) Deposition of accidentally introduced exogenous materials
  4. Classification of pigmented disease Physiologic or pathologic Endogenous or exogenous Reversible or irreversible melanocytic or nonmelanocytic Benign or malignant focal, multifocal, or diffuse in its presentation. Iatrogenic :Exogenous . chronic
  5. Focal pigmented lesions. Algorithm illustrating clinical procedures needed to segregate and diagnose common focal pigmented lesion
  6. Multifocal and diffuse pigmented lesions. Algorithm illustrating the clinical presentation of pigmented lesions with accompanying habits, endoscopic features, and
  7. Oral melanoma
  8. Bilateral oral melanoacanthoma in an Indian boy
  9. oral compound nevus of retromolar
  10. Oral melanotic macule gingiva
  11. Ephelis or freckles of the lower vermilion border. Brown pigmented macule with circumscribed borders on the left lower vermilion border usually occur on sun exposed area
  12. a melanotic macule does not become darker with continued sun exposure. Unlike ephelides
  13. Pretreatment amalgam tattoo on the keratinized
  14. . A. Ulcerative lesions involving buccal mucosa in a patient affected by OLP. B. OPP disclosed after inflammation resolution
  15. Smokers melanosis
  16. Hard palate hyperpigmentation secondary to chronic chloroquine
  17. Imatinib‐induced pigmentation of the palate. A 65‐year‐old white female treated with imatinib for gastrointestinal stromal tumor. Courtesy of Dr. Suman Sra,private practice, San Jose, CA, USA
  18. Peutz-Jeghers Syndrome (Perioral Lesions) © Springer Science+Business Media
  19. Addison’s disease. (A) Patchy brown areas of pigmentations in the labial mucosa of an individual with Addison’s disease. Courtesy of Dr. Jose Castillo, School of Dentistry, University Mayor, Santiago, Chile
  20. Conditions with high ACTH and hyperpigmentation
  21. Laugier–Hunziker pigmentation. Multiple pigmented macules were observed in this healthy female who underwent colonoscopy and laboratory studies that ruled out Peutz–Jeghers syndrome and Addison’s disease. This multifocal pattern of pigmentation is reminiscent of Peutz–Jeghers syndrome.
  22. Common Causes of Endogenous Oral and Perioral Discoloration
  23. Sources of Exogenous Oral and Perioral Pigmentation
  24. Lesions that May Be Associated with Oral Mucosal Discoloration
  25. How the discoloration occurs? Overproduction of melanin may be caused by a variety of mechanisms, the most common of which is related to increased sun exposure. intraorally, hyperpigmentation is more commonly a consequence of physiologic or idiopathic sources, neoplasia, medication or oral contraceptive use, high serum concentrations of pituitary adrenocorticotropic hormone (ACTH), postinflammatory changes, and genetic or autoimmune disease melanin is synthesized within specialized structures known as melanosomes. melanin is actually composed of eumelanin, which is a brown-black pigment, and pheomelanin, which has a red-yellow color melanosis is frequently used to describe diffuse hyperpigmentation
  26. Etiology of Multifocal, Diffuse, or Generalized Mucocutaneous Melanosis
  27. Pigmentation diagnosis.
  28. Diagnosis of perioral and oral mucosal pigmented disease • Patient bio especially the race • Clinical oral and with or without systemic manifestation • clinical tests, including diascopy, radiography . • blood tests • dermascopy, also known as epiluminescence microscopy for melanocytic lesions. although current instrumentation is designed primarily for the study of cutaneous pigmentation, several studies have described the use of dermascopy in the evaluation of labial and anterior lingual pigmentation • binocular stereo microscopes with or without the assistance of digital technology and imaging software. this diagnostic technique has been shown to be effective in discriminating melanocytic from nonmelanocytic lesions and benign versus malignant melanocytic processes.
  29. AI assisted diagnosis • the dermoscope and its associated intelligent dermoscopy software) have been quick to become necessary medical tools for the examination of all types of pigmented conditions. Due to the strong associations with artificial intelligence in dermatology, big data, interoperability, data security and cloud-based software, digital dermoscopy tools are set to evolve and improve at an impressive rat
  30. Focal melanocytic Pigmentation Freckle/Ephelis Oral/Labial Melanotic Macule Oral Melanoacanthoma Melanocytic nevus Malignant Melanoma
  31. Focal lesions of clinical similarities Melanotic macules, which consist of increased melanin, without increased numbers of melanocytes. Ephelides with sun exposure change in the amount of melanin and consequently color, but melanotic macules do not.  Melanoacanthomas – rare acquired brown to black, usually single, benign areas of pigmentation of the mucosa, which can arise suddenly and enlarge, commonly seen on the buccal mucosa of women of African heritage. Besides increased amount of melanin in the basal layer they also typically show dendritic cells with melanin and eosinophils in the upper epithelium. They may be melanotic macules that appear suddenly
  32. Melanotic macule • Definition: Melanotic macule is an acquired, small, flat, brown to brown-black, asymptomatic, benign lesion, unchanging in character. Prevalence (approximate): 1 in 1000 adults. Age mainly affected: Adults. Gender mainly affected: F > M. Etiopathogenesis: The oral melanotic macule is a focal increase in melanin deposition. Labial melanotic macule (on the lip vermilion) is regarded as a distinct entity. Melanotic macules are usually seen in isolation but may also be seen in: • Peutz-Jeghers syndrome – an autosomal dominant trait related to serine/threonine kinase gene, characterized by mucocutaneous melanotic macules, especially circumorally and hamartomatous intestinal polyposis mainly in the small intestine, which rarely undergo malignant change but can produce intussusception (obstruction). The risk of gastrointestinal, pancreatic, breast and reproductive carcinomas is slightly increased • Laugier–Hunziker syndrome – a benign condition of labial, oral, skin and nail hyperpigmentation Genital involvement is not uncommon. • HIV infection – most are related to primary adrenocortical deficiency or to zidovudine therapy
  33. • History Asymptomatic oral melanotic macules unchanging in character. • Clinical features Most are solitary and seen in white adults and their color ranges from brown to black. Many macules occur on the vermilion border of the lower lip as solitary lesions (labial melanotic macules). Intraorally, the anterior gingivae, buccal mucosa, and palate are the main sites, and more than one lesion may be detected The typical macule is a small well-demarcated, uniformly tan to dark brown, round or oval discoloration < 7 mm diameter
  34. . Differential diagnosis: Tattoos, nevi, melanoma. Biopsy/histopathology may be indicated if the lesion clinically resembles early melanoma, especially if it develops rapidly. Histopathologically the stratified squamous epithelium is normal apart from increased pigmentation within the keratinocytes of the basal and parabasal layers, accentuated at the tips of rete ridges. There is negative staining for HMB- 45 (homatropine methylbromide) while nevi are positively staining. There are no nevus cells or elongated rete ridges. There is melanin in the epithelial basal layer and/or upper lamina propria. Deposits may also be seen within subepithelial stroma (melanin incontinence), perhaps within macrophages or melanophages. Brown malinin deposits can be differentiated from iron deposits by their association with erythrocytes rather than with basal layer epithelial cells. There is no underlying inflammatory response
  35. Management The intraoral melanotic macule has no malignant transformation potential, but an early melanoma could have a similar clinical appearance, so lesions of recent onset, large size, irregular pigmentation, unknown duration, or enlarging should be excised and examined histopathologically. No treatment is required otherwise, except for cosmetic considerations (excision or removal by laser or hidden by lipstick). Prognosis Excellent.
  36. Malignant melanoma • Definition: Malignant neoplasm of melanocytes. Prevalence (approximate): Uncommon – probably 1.2 cases per 10 million population per year. Japan and Uganda are areas of higher prevalence. Oral melanoma accounts for 0.2–8% of melanomas and approximately 1.6% of all head and neck malignancies. • The oral mucosa is primarily involved in less than 1% of melanomas. Age mainly affected: Middle-aged and older. Gender mainly affected: M > F. Etiopathogenesis: Sunlight exposure is causal in skin melanomas, which have increased in almost epidemic fashion over the past decades, especially in fair-skinned peoples. • The cause of oral melanoma, however, is unknown and no link has been established with chemical or physical trauma, tobacco use, betel chewing or oral hygiene. • Most oral melanomas are thought to arise de novo. Though oral nevi are potential sources of some melanomas they are usually benign. Even blue nevi, which are more common on the palate – the site of predilection for melanoma – rarely undergo malignant transformation
  37. Diagnostic features History: Melanomas are usually symptomless in early stages; later swelling, tooth mobility, or bleeding may appear. Clinical features The most common oral locations are the palate and maxillary gingiva. Metastatic melanoma most frequently affects the mandible, tongue, and buccal mucosa. Oral melanoma often is overlooked or clinically misinterpreted as a benign pigmented process until it is well advanced and it frequently presents with metastases in lymph nodes, liver and lungs. Radial (horizontal spread) and vertical (infiltrative) extension is common at the time of diagnosis. Pigmented solitary small brown or black macules 1.0 mm to 1.0 cm or larger are found They grow rapidly, initially spreading radially and superficially, later become increasingly pigmented, nodular, deeply invasive and with satellite lesions. Up to 10% are non-pigmented
  38. Clinical presentation of cases, a diffuse and painless asymptomatic swelling (approximately 3.0 cm of size) covered by erythematous lining mucosa. The tumor extended to the oropharynx region and caused difficulty in swallowing and phonation. (B) the patient presented a small asymptomatic sessile nodule, 0.5 cm, bleeding on palpation, in the region of the incisive papilla between lower central incisors with a clinical diagnosis of pyogenic granuloma. (C), the patient presented an asymptomatic swelling showing areas of ulceration in the upper left alveolar ridge Amelanotic melanoma
  39. Occasionally melanomas are nodular ab initio with deep spread,or are multiple or large. Features suggestive of malignancy include a rapid increase in size, change in color, ulceration, pain, bleeding, the occurrence of satellite pigmented spots, or regional lymph node enlargement. Differential diagnosis: Melanotic macule, nevus, tattoos, melanoacanthoma and Kaposi sarcoma. Rubbing with a cotton pledget may elicit brown pigmentation
  40. Histology: may show anaplastic spindle-shaped or squamoid cells. The epithelium is abnormal, with large atypical melanocytes and excessive melanin. The melanoma cells have large nuclei, often with prominent nucleoli, and show nuclear pseudoinclusions due to nuclear membrane irregularity. The abundant cytoplasm may be uniformly eosinophilic or optically clear. Occasionally, the cells become spindled,a finding interpreted as a more aggressive feature. However, the histology is quite varied and staining with dopa or antibodies may be required to help the diagnosis. Melanoma stains positively with S100, tyrosinase, Mart-1/melan-A, vimentin, microphthalmic transcription factor, and homatropine methylbromide (HMB-45). Immunohistochemistry: though helpful to differentiate melanoma from other tumors, cannot differentiate from nevus (usually atypical nevus)
  41. Imaging modalities in melanoma • Imaging is needed to exclude invasion. Contrast-enhanced CT can be used to determine the extent of the melanoma and whether local, regional, or lymph node metastasis is present. MRI is used to diagnose melanoma in soft tissue. • Bone scanning with gadolinium-based agents and chest radiography can be beneficial in assessing metastasis. Positron emission tomography (PET) has poor results in distinguishing melanoma from nevi. However, combined PET- CT may have diagnostic value
  42. Melanoma management • The optimal treatment is surgery with neck dissection if regional lymph nodes are involved. Prophylactic neck dissection is not advocated as a treatment. Early surgical intervention when local recurrence is detected enhances survival, because dismal outcomes are associated with distant metastasis. • Radiation and chemotherapy are unhelpful. However, although radiation alone is reported to have questionable benefit (particularly in small fractionated doses), it is a valuable adjuvant in achieving relapse free survival when high-fractionated doses are used. • Drug therapies used in the treatment of cutaneous melanoma (dacarbazine in conjunction with interleukin-2 (IL-2)), and immunotherapy, are of questionable benefit in oral melanoma. There are anecdotal reports of benefit from interferon alfa (INF-A). • Many centers, however, follow surgery with IL-2 adjunctive therapy to prevent or limit recurrence
  43. Melanoma prognosis • The prognosis is poor and worse than skin melanomas, unless detected very early, but many patients present in advanced stage with involvement of cervical nodes and distant metastases to lung or liver. The five-year survival rate is generally 5–50%. • Tumor thickness or volume (Clark and Breslow indices) and lymph node metastasis are less reliable prognostic indicators than they are in skin (where lesions thinner than 0.75 mm rarely metastasize)
  44. Multifocal/diffuse Pigmentation Physiologic Pigmentation drug-induced Melanosis smoker’s Melanosis Postinflammatory (inflammatory) hyperpigmentation Melasma (Chloasma) melanosis associated with systemic or genetic disease hemoglobin and iron associated Pigmentation drug-induced Pigmentation
  45. Medications Associated with Mucocutaneous Pigmentation
  46. Melanosis associated with systemic or genetic disease hypoadrenocorticism (adrenal insufficiency, Addison's disease) Cushing’s syndrome/Cushing’s disease hyperthyroidism (graves’ disease Primary Biliary Cirrhosis Vitamin B 12 (Cobalamin) defciency Peutz-Jeghers syndrome hiV/aids-associated Melanosis Laugier-hunziker Pigmentation
  47. gastrointestinal disease, cancer susceptibility, and mucocutaneous pigmented macules triats Peutz-Jeghers syndrome Cowden syndrome the allelic bannayan-riley-ruvalcaba syndromes lhermitte-duclos syndromes) cronkhite-Canada syndrome.
  48. Café au Lait Pigmentation Diseases Commonly Associated with Café au Lait Pigmentation
  49. Depigmentation ( Vitiligo ) • Vitiligo is a relatively common, acquired, autoimmune disease that is associated with hypomelanosis. the pathogenesis of vitiligo is multifactorial, with both genetic and environmental factors likely to play a role in disease pathogenesis. identified a single nucleotide polymorphism in a vitiligo-susceptibility gene that is also associated with susceptibility to other autoimmune diseases, including diabetes type 1, systemic lupus erythematosus, and rheumatoid arthritis. Additional putative vitiligo-susceptibility genes have been mapped to various other chromosomal regions
  50. •Clinical presentation • Age at any age but common at second decade • Sex no sex predilection • site at any site occur bilaterally on the lip (lip vitiligo). the skin and hair of most of the body may lose its pigmentation (vitiligo universalis) • Shape: vitiligenous lesions often present as well-circumscribed, round, oval or elongated, pale or • white-colored macules that may coalesce into larger areas of diffuse depigmentation. As the • disease progresses, additional areas of involvement may become apparent. • Vitiligo may also arise in patients undergoing immunotherapy for the treatment of malignant melanoma
  51. pathology microscopically, there is a complete loss of melanocytes and melanin pigmentation in the basal cell layer. the use of histochemical stains such as Fontana-masson will confirm,,the absence of melanin. Management topical corticosteroids and topical or, more commonly, systemic photochemotherapies (psoralen and ultraviolet a exposure) have proven to be effective nonsurgical therapies labial vitiligo is more resistant to the typical treatments used for cutaneous vitiligo. due to a lack of hair follicles, the lips do not have a reservoir of melanocytes that can be stimulated to produce pigment., surgical intervention may be the only option .
  52. • focal areas of depigmentation. in other patients, an entire segment on one side of the body may be affected. in occasional patients, the skin and hair of most of the body may lose its pigmentation (vitiligo universalis). in most cases, vitiligo is characterized by bilateral, symmetric areas of relatively generalized hypomelanosis. the vitiligenous lesions often present as well-circumscribed, round, oval or elongated, pale or white-colored macules that may coalesce into larger areas of diffuse depigmentation. as the disease progresses, additional areas of involvement may become apparent Depigmentation in palate
  53. Management ofmucocutaneous pigmented disease Treatment modality depends on lesion type and behavior Cause modification or elimination surgical intervention is less of an option for the treatment  laser therapy: Various types of lasers have been used, including superpulsed co2, Q-switched nd-yag, and Q-switched alexandrite lasers.
  54. cryotherapy have been used to successfully treat such cases. phototherapy have also been employed, including intense pulsed light. and fractional photothermolysis.  bleaching creams :a combination of 4%
Anúncio